Globus Medical announced preliminary 4Q18 revenue of US $195.5MM, +11% vs. 4Q17, and full-year 2018 revenue of $712.5MM, +12% vs. 2017.
This marks the fifth consecutive quarter of double-digit organic growth for the company, driven in part by 35% year-over-year growth for the ExcelsiusGPS robotic platform. In the U.S., spinal implants grew 9%, which leadership attributed to robotic-system pull through and strong recruiting. Globus provided full-year 2019 guidance of $770MM.
Source: Globus Medical
Mike Evers is ORTHOWORLD’s Market Analyst. He can be reached by email.
Globus Medical announced preliminary 4Q18 revenue of US $195.5MM, +11% vs. 4Q17, and full-year 2018 revenue of $712.5MM, +12% vs. 2017.
This marks the fifth consecutive quarter of double-digit organic growth for the company, driven in part by 35% year-over-year growth for the ExcelsiusGPS robotic platform. In the U.S., spinal implants grew 9%,...
Globus Medical announced preliminary 4Q18 revenue of US $195.5MM, +11% vs. 4Q17, and full-year 2018 revenue of $712.5MM, +12% vs. 2017.
This marks the fifth consecutive quarter of double-digit organic growth for the company, driven in part by 35% year-over-year growth for the ExcelsiusGPS robotic platform. In the U.S., spinal implants grew 9%, which leadership attributed to robotic-system pull through and strong recruiting. Globus provided full-year 2019 guidance of $770MM.
Source: Globus Medical
Mike Evers is ORTHOWORLD’s Market Analyst. He can be reached by email.
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
ME
Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.